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Abstract
Background: Laser capture microdissection (LCM) can be applied to tissues where cells of interest are
distinguishable from surrounding cell populations. Here, we have optimized LCM for fresh frozen normal breast
tissue where large amounts of fat can cause problems during microdissection. Since the amount of DNA needed
for genome wide analyses, such as single nucleotide polymorphism (SNP) arrays, is often greater than what can be
obtained from the dissected tissue, we have compared three different whole genome amplification (WGA) kits for
amplification of DNA from LCM material. In addition, the genome wide profiling methods commonly used today
require extremely high DNA quality compared to PCR based techniques and DNA quality is thus critical for
successful downstream analyses.
Findings: We found that by using FrameSlides without glass backing for LCM and treating the slides with acetone
after staining, the problems caused by excessive fat could be significantly decreased. The amount of DNA obtained
after extraction from LCM tissue was not sufficient for direct SNP array analysis in our material. However, the two
WGA kits based on Phi29 polymerase technology (Repli-g
® (Qiagen) and GenomiPhi (GE Healthcare)) gave
relatively long amplification products, and amplified DNA from Repli-g
® gave call rates in the subsequent SNP
analysis close to those from non-amplified DNA. Furthermore, the quality of the input DNA for WGA was found to
be essential for successful SNP array results and initial DNA fragmentation problems could be reduced by
switching from a regular halogen lamp to a VIS-LED lamp during LCM.
Conclusions: LCM must be optimized to work satisfactorily in difficult tissues. We describe a work flow for fresh
frozen normal breast tissue where fat is inclined to cause problems if sample treatment is not adapted to this
tissue. We also show that the Phi29-based Repli-g
® WGA kit (Qiagen) is a feasible approach to amplify DNA of high
quality prior to genome wide analyses such as SNP profiling.
Findings
Background
Laser capture microdissection (LCM) is a widely used
method for isolation of defined cell populations from
heterogeneous tissue sections. The method allows selec-
tion of unmixed starting material for DNA, RNA or pro-
tein extraction for further downstream molecular
analyses [1-3]. However, LCM needs to be optimized
depending on tissue type, for example normal breast tis-
sue contains more lipids than breast tumor tissue. The
PALM MicroBeam system (Carl Zeiss MicroImaging,
Jena, Germany) is one of several commercially available
LCM systems. This system utilizes a UV laser to cut
around the selected cells and a pulse from the same
laser to catapult the selected specimen into a collection
device, e.g. an AdhesiveCap microcentrifuge tube (Carl
Zeiss MicroImaging). In order to catapult larger tissue
structures with a single laser pulse, slides with thin poly-
ethylene membranes are used. There are two types of
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slides covered by the membrane and FrameSlides where
the membrane is only supported by a metal frame.
The amount of DNA yielded by LCM can be sufficient
for PCR based analyses, but is often insufficient for gen-
ome-wide applications such as high density single
nucleotide polymorphism (SNP) genotyping arrays.
Whole genome amplification (WGA) provides a possibi-
lity to amplify a small amount of high quality DNA and
there are several WGA methods available. Many WGA
kits on the market today employ the multiple displace-
ment amplification (MDA) technology (e.g. GenomiPhi
(GE Healthcare Life Sciences, Uppsala, Sweden) and
Repli-g
® (Qiagen, Hilden, Germany)). This Phi29 DNA
polymerase-based technique has in many studies been
found to provide the most balanced genome amplifica-
tion to date [4-7]. The concordance between non-ampli-
fied and MDA amplified DNA in SNP arrays has been
found to be higher than 98% [8-10] and a majority of
studies report MDA WGA to be the method of choice
for SNP array analyses [5,11,12]. However, the key to
accurate WGA is high quality input DNA and the DNA
quality after LCM is difficult to investigate since the
small amount of DNA obtained after microdissection
restricts the methods available for quality assurance.
In this study, we have developed a protocol for LCM
of fresh frozen normal breast tissue to enable microdis-
section of this challenging, fat rich tissue. We have also
tested three different, commercially available, WGA kits
to obtain sufficient amounts of high quality DNA for
high-density SNP array analysis.
Tissue preparation and laser capture microdissection
(LCM)
Samples of histologically normal breast tissue were col-
lected from women who had undergone a prophylactic
mastectomy due to increased risk of developing breast
cancer (see Rennstam et al [13] for details). Informed
consent forms were signed by all women included in the
study and the study was approved by the ethics commit-
tee at Lund University, Sweden. The tissue was snap fro-
zen and kept at -80°C. On the day of LCM, 16 μm
sections were cut at -20°C in a cryostat and placed on
MembraneSlides (Carl Zeiss MicroImaging). Cresyl vio-
let staining performed according to a standard protocol
from Zeiss Labs, Munich, Germany (http://www.zeiss.
de/ microdissection) gave a distinct nuclear staining
that made it easy to identify breast ducts and lobules
(Figure 1a). This protocol included fixation in 70% etha-
nol (EtOH) for 2 minutes followed by staining with a
Cresyl Violet (CV) solution (1% w/v in 50% EtOH) for
45 seconds before washing and dehydration, first in 70%
EtOH and then in 100% EtOH, 10 dips in each. When
using MembraneSlides, “bubbles” formed underneath
the tissue (Figure 1b) and caused focusing problems,
making cutting virtually impossible. Assisted by Zeiss
Labs, Munich, Germany (personal communication) we
realized that the bubbles were caused by lipids leaking
through the membrane. By switching from Membrane-
Slides to FrameSlides (Carl Zeiss MicroImaging) this
problem was solved. Also, by adding a 20 second rinse
in acetone as the last step in the staining protocol, more
fat was dissolved and the catapulting improved greatly.
It should be noted, however, that acetone weakens the
adhesion of the tissue to the membrane and rinses
longer than 20 seconds should be avoided. Acetone was
chosen instead of xylene, since PALM Protocols from
Zeiss Labs advise against using xylene, due to increased
tissue brittleness as well as decreased adhesion to the
membrane. An example of a typical area for LCM is
s h o w ni nF i g u r e1 c - f .N o t et h eb r i d g e ,w h i c hi s
left uncut to prevent the tissue from dropping down
(Figure 1d). This bridge is also used as the point of cata-
pulting. Unexpectedly, LCM was found to negatively
affect the quality of the resulting genomic DNA (gDNA)
(Figure 2a), thereby influencing subsequent SNP array
analyses. The problem could be solved by switching
from the standard halogen lamp to a VIS-LED lamp
which generates noticeably less heat in the LCM micro-
scope. The time spent on LCM (1, 2 or 3 hours) did not
visibly affect the DNA quality (Figure 2b).
DNA extraction and whole genome amplification (WGA)
DNA was extracted directly after dissection using the
QIAmp DNA Micro kit (Qiagen) according to their specific
protocol for extraction of genomic DNA from LCM tissues.
A few modifications were made to the protocol: Buffer ATL
and proteinase K were mixed before addition to the Adhe-
siveCap and no vortexing of the tubes was performed
before 4 hours incubation at 56ºC in an up-side-down posi-
tion. DNA concentrations were measured on the Qubit™
quantification platform using the Quant-iT™ high sensitiv-
ity assay for double stranded DNA (dsDNA) (Invitrogen,
Carlsbad, CA). The DNA yield was approximately 30 ng
DNA per mm
2 of microdissected tissue.
For WGA, three different methods were tested on a pool
of high quality DNA extracted from blood as well as on
DNA from LCM tissue. Different concentrations of DNA
were tested as input from LCM samples (Table 1). For all
three kits the protocols provided by the manufacturers
were carefully followed and the concentration of dsDNA
after WGA was determined using the Quant-iT™ broad
range assay (Invitrogen). The DNA input and average out-
put are summarized in Table 1. The size and quality of the
amplified fragments were examined on a 0.5% agarose gel
stained with ethidium bromide. Between 150 and 200 ng
DNA were loaded in each lane. The first WGA kit,
Repli-g
® from Qiagen uses Phi29 DNA polymerase to
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fragments was longer than 10 kb, suggesting high DNA
quality suitable for SNP arrays (Figure 3). There is also a
user-developed protocol for direct WGA of microdissected
tissue available at Qiagen’s homepage (http://www.qiagen.
com). This protocol was tested with an approximately 1
mm
2 input area of LCM tissue and the amplification pro-
ducts were found to be surprisingly long (data not shown).
However, SNP array call rates clearly discourage this
method of amplification before SNP array studies (Table
2). The second kit, GenomiPhi V2 DNA amplification kit
(GE Healthcare) is also a Phi29 based MDA kit and the
quality of the amplification product was relatively high,
with many fragments longer than 3 kb (Figure 3). Finally,
the BioScore™ FFPE Screening and Amplification kit
(Enzo Life Sciences), which is developed especially for for-
malin-fixed paraffin-embedded tissue that is normally dif-
ficult to amplify due to fragmented and cross-linked DNA,
Figure 1 Cresyl Violet stained breast tissue. a) Low magnification overview, scanned with a MiraxViewer slide scanner; b) Illustration of how
lipids from normal breast tissue can collect between the membrane and the slide on MembraneSlides and cause technical difficulties; c)
Overview of the LCM area; d) Cut line around structure of interest; e) Area after catapulting; f) Catapulted piece collected in the cap.
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mechanism that is not disclosed to the customer (Enzo
Life Sciences, personal communication). Here, this proto-
col gave the highest DNA yield but it also required the
highest input amounts (Table 1). The DNA quality, with
many short fragments, was clearly inferior to the other kits
(Figure 3) and it should be noted that the price for this
more specialized kit is considerably higher.
SNP array
SNP analyses were run on Infinium Human Omni 1 M
arrays (Illumina, San Diego, CA) at the Swegene Centre
for Integrative Biology at Lund University (SCIBLU)
genomics facility (Lund University, Sweden). Data ana-
lyses were performed in Illumina’s GenomeStudio
®
Genotyping Module. The SNP array call rates are listed
in Table 2 and show that amplification products from
both blood and tissue with the Repli-g
® kit (Qiagen)
give call rates comparable to what was obtained with
non-amplified blood and tissue. Non-amplified DNA,
however, showed less noise in the SNP profiles. Geno-
miPhi and BioScore™ amplified DNA from blood
caused more noise in the SNP analysis and also dis-
played clearly lower call rates than non-amplified DNA
from blood. These kits were therefore not further
applied to DNA from LCM tissue. Interestingly, the
direct-amplified (Repli-g
®, Qiagen) LCM tissue without
previous DNA extraction gave extremely poor call rates,
and the high noise level suggests that this amplification
method is clearly not suited before genome wide
analyses.
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Figure 2 Visualization of DNA on 0.5% agarose gels stained
with EtBr after a) dissection under standard halogen lamp
(Lane 1 = good quality genomic DNA (gDNA) from blood, Lane
2 = fragmented DNA after LCM for approximately 2 hours)
and; b) after 1, 2 or 3 hours of LCM under a VIS-LED lamp.
Table 1 WGA using three different commercial kits on DNA extracted from microdissected tissue and from blood
DNA SOURCE
LCM tissue Blood
Recommended
input (μg)
Expected
output (μg)
Input (μg) Output (μg) Input (μg) Output (μg)
Repli-g
® (Qiagen) >0.010 Approx. 10 0.015-0.030 2.0 (0.5-5.1) 0.013 5.2 (3.9-6.5)
GenomiPhi
(GE Healthcare)
>0.010 4-7 0.013-0.050 2.0 (1.1-3.6) 0.013 4.5 (4.2-4.8)
BioScore™ (Enzo Life
Sciences)
0.100 >10 0.040-0.100 12.9 (11.9-14.3) 0.100 11.8 (10.3-13.3)
The recommended input and expected output are noted for each kit as well as the results from this experiment. The output from this experiment is given as
mean values and the range within brackets.
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Figure 3 Amplification products from the three different WGA
kits on a 0.5% agarose gel stained with EtBr.
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We have developed a protocol for LCM of fresh frozen
normal breast tissue, which is a demanding tissue to
work with and we believe the method to be valid for
other lipid-rich tissues as well. A switch to FrameSlides
and an added acetone wash were necessary for LCM to
work adequately. When using FrameSlides, however, it
was obvious that some tissue was dropped and could be
found on the objective below the stage. This loss,
together with other pieces that were not successfully
catapulted into the cap, was estimated to approximately
10% and is in line with observations made by other
groups [14]. Interestingly, other groups working with
breast tissue have not described problems with LCM.
However, much of the previous work has been per-
formed on paraffin embedded tissue [15,16] where all
lipids have been removed during the embedding process.
For frozen sections, most work has been performed on
breast tumor tissue [2,17], which contains considerably
less adipose cells than normal breast tissue. To our
knowledge, in the few studies where normal fresh frozen
breast tissue has been studied, LCM systems by Arc-
turus Engineering have been used [18-22]. Possibly,
these systems are less sensitive to contaminating lipids.
We performed a thorough quality control of DNA
obtained from LCM tissue after recognizing that a lack
of long fragments in the input to WGA did not result in
unsuccessful amplification but was only observable as
low SNP array call rates. As displayed in the gel image
in Figure 2a, the majority of the LCM DNA fragments
were shorter than 4 kb. We found that the original halo-
gen lamp in the LCM microscope was causing DNA
fragmentation during microdissection, probably due to
heat production. After changing to a VIS-LED lamp,
clearly higher DNA quality was obtained (Figure 2b).
We suspect that poor DNA quality is often a problem
in the analysis of DNA obtained from LCM, but that
this is rarely discovered since the small amount of DNA
limits the options for quality control of long fragment
DNA. Most likely, the DNA quality after LCM is suffi-
cient for most PCR-based assays and possibly for other
less sensitive analyses. However, we found that for SNP
array analyses the quality of the input DNA is crucial
for a successful outcome after WGA.
The amplification products after WGA clearly dif-
fered in DNA yield and quality (Table 1 and Figure 3).
The BioScore™ WGA kit is developed for formalin-
fixed, paraffin-embedded tissue and as a consequence,
the amplification products are noticeably shorter than
from the other two kits (Figure 3). Since our material
is fresh-frozen, we had the possibility to use one of
the two MDA-based kits that give clearly longer
amplification products. According to the literature,
Qiagen’sR e p l i - g
® kit is often the method of choice for
w h o l eg e n o m ea m p l i f i c a t i o nb e f o r eS N Pa r r a ya n a l y s e s
[10,11,23] whereas the GenomiPhi kit (GE Healthcare)
is often chosen when working with microdissected tis-
sue [24-27]. We tested both the GenomiPhi and Repli-
g
® methods and found that the Repli-g
® kit gave DNA
fragments of approximately the same size as genomic
DNA (Figure 3). The GenomiPhi kit also gave pro-
ducts longer than approximately 1 kb and up to more
than 10 kb. We did not find a correlation between the
amount of starting material in the WGA reactions and
the output after amplification. However, the quantity
of starting material has previously been shown to
affect the level of amplification bias in the product.
Arriola et al. [28] showed that an input of 0.5-10 ng
resulted in a higher amplification bias than when lar-
ger amounts of starting DNA were used. It is there-
fore suggested that the same amount of starting
material should be used in both test and reference
samples since copy number change biases were found
to be non-random [9,28]. Our results also show a dif-
ference in call rates between amplified and non-ampli-
fied products, thus indicating that the reference and
test samples should indeed be treated equally in this
respect. However, call rates for MDA products have
generally been found to be high and sometimes even
comparable with call rates for genomic DNA [9,10].
We found this to be true in Repli-g
® amplified DNA
(Table 2) and thus suggest that whole genome amplifi-
cation with this kit is best suited for SNP array ana-
lyses. Nevertheless, amplified DNA tends to yield
noisier data and adequate normalization and filtering
always need to be performed by the user. The flow
chart in Figure 4 summarizes the different steps sug-
gested for LCM and WGA before SNP array analysis
of DNA from normal breast tissue.
Table 2 Call rates for SNP arrays
Blood LCM tissue
Non-amplified 0.997* 0.997**
Repli-g
® 0.994* 0.987**
Direct ampl. Repli-g
® 0.755
BioScore™ 0.975*
GenomiPhi 0.956*
DNA from blood and LCM tissue was amplified with different commercial kits.
Stars indicate that input DNA comes from the same pool of DNA extracted
from blood (*) or LCM tissue (**), respectively. Call rates for non-amplified
DNA and WGA products from Repli-g
® (bold) are comparable and suggest
that this method is best suited for whole genome amplification before SNP
array analysis.
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